{
    "2020-02-17": [
        [
            {
                "time": "",
                "original_text": "智通港股公告精选︱(2.17)白云山子公司将迅速恢复生产磷酸氯喹片",
                "features": {
                    "keywords": [
                        "白云山",
                        "子公司",
                        "磷酸氯喹片",
                        "恢复生产"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "白云山：子公司将在疫情期间恢复“磷酸氯喹片”生产",
                "features": {
                    "keywords": [
                        "白云山",
                        "子公司",
                        "疫情期间",
                        "磷酸氯喹片",
                        "恢复生产"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "白云山：子公司收到磷酸氯喹片《药品补充申请批件》，将迅速恢复该药品生产",
                "features": {
                    "keywords": [
                        "白云山",
                        "子公司",
                        "磷酸氯喹片",
                        "药品补充申请批件",
                        "恢复生产"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "白云山(00874-HK)：子公司磷酸氯喹片获药品补充申请批件",
                "features": {
                    "keywords": [
                        "白云山",
                        "子公司",
                        "磷酸氯喹片",
                        "药品补充申请批件"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "异动直击|获磷酸氯喹片药品补充申请批件，白云山高开3%",
                "features": {
                    "keywords": [
                        "白云山",
                        "磷酸氯喹片",
                        "药品补充申请批件",
                        "高开"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}